Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.

Rossini M, Rizzo P, Bononi I, Clementz A, Ferrari R, Martini F, Tognon MG.

Front Oncol. 2018 Apr 3;8:91. doi: 10.3389/fonc.2018.00091. eCollection 2018. Review.

2.

Utilization of discard bovine bone as a support for immobilization of recombinant Rhizopus oryzae lipase expressed in Pichia pastoris.

Clementz AL, Del Peso G, Canet A, Yori JC, Valero F.

Biotechnol Prog. 2016 Sep;32(5):1246-1253. doi: 10.1002/btpr.2321. Epub 2016 Jul 12.

PMID:
27339042
3.

The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors.

Rizzo P, Mele D, Caliceti C, Pannella M, Fortini C, Clementz AG, Morelli MB, Aquila G, Ameri P, Ferrari R.

Front Oncol. 2015 Jan 13;4:384. doi: 10.3389/fonc.2014.00384. eCollection 2014. Review.

4.

Collagen XV: exploring its structure and role within the tumor microenvironment.

Clementz AG, Harris A.

Mol Cancer Res. 2013 Dec;11(12):1481-6. doi: 10.1158/1541-7786.MCR-12-0662. Epub 2013 Sep 16. Review.

5.

Collagen XV inhibits epithelial to mesenchymal transition in pancreatic adenocarcinoma cells.

Clementz AG, Mutolo MJ, Leir SH, Morris KJ, Kucybala K, Harris H, Harris A.

PLoS One. 2013 Aug 22;8(8):e72250. doi: 10.1371/journal.pone.0072250. eCollection 2013.

6.

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence.

Pandya K, Meeke K, Clementz AG, Rogowski A, Roberts J, Miele L, Albain KS, Osipo C.

Br J Cancer. 2011 Sep 6;105(6):796-806. doi: 10.1038/bjc.2011.321. Epub 2011 Aug 16.

7.

NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.

Clementz AG, Rogowski A, Pandya K, Miele L, Osipo C.

Breast Cancer Res. 2011 Jun 14;13(3):R63. doi: 10.1186/bcr2900.

8.

Notch versus the proteasome: what is the target of gamma-secretase inhibitor-I?

Clementz AG, Osipo C.

Breast Cancer Res. 2009;11(5):110. doi: 10.1186/bcr2407.

9.

ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.

Osipo C, Patel P, Rizzo P, Clementz AG, Hao L, Golde TE, Miele L.

Oncogene. 2008 Aug 28;27(37):5019-32. doi: 10.1038/onc.2008.149. Epub 2008 May 12.

PMID:
18469855
10.

Effect of single-site charge-reversal mutations on the catalytic properties of yeast cytochrome c peroxidase: evidence for a single, catalytically active, cytochrome c binding domain.

Pearl NM, Jacobson T, Meyen C, Clementz AG, Ok EY, Choi E, Wilson K, Vitello LB, Erman JE.

Biochemistry. 2008 Mar 4;47(9):2766-75. doi: 10.1021/bi702271r. Epub 2008 Jan 31.

PMID:
18232645

Supplemental Content

Loading ...
Support Center